At a recent reception at the residence, I began to suspect it might be my lounge. The reason was that the room was crammed with over 80 guests representing the cream of the Ukrainian medical profession and, in particular, many of the country’s top interventional cardiologists.
Other medical experts with whom I chatted included trained first response specialists. If anyone planned to fall ill, this was the place.
The occasion for the reception was an event organised for AstraZeneca, an international biopharmaceutical company with its HQ in London, to mark the creation of the Association of Interventional Cardiologists of Ukraine.